• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

VDR Genotypes Predict Vitamin D Response in Juvenile Arthritis

by
November 7, 2026
in Health
Reading Time: 6 mins read
0
VDR Genotypes Predict Vitamin D Response in Juvenile Arthritis

VDR Genotypes Predict Vitamin D Response in Juvenile Arthritis

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a prospective observational case-control study conducted at Tanta University Hospitals in Egypt, researchers identified specific genetic variations in the vitamin D receptor (VDR) gene that are associated with the magnitude of serum vitamin D increase following supplementation in children with juvenile idiopathic arthritis (JIA). The study, published in the Egyptian Rheumatology and Rehabilitation journal, examined 120 children diagnosed with JIA and 100 healthy controls, aiming to clarify the relationship between VDR polymorphisms, baseline vitamin D status, and the clinical response to standardized vitamin D therapy. The findings suggest that while vitamin D deficiency is highly prevalent in JIA patients, the genetic background of the vitamin D receptor may influence how effectively the body metabolizes and responds to supplemental vitamin D, although the study authors caution that these associations were also observed in healthy controls.

The research team, led by Hanaa El-Banna and colleagues, focused on four extensively studied single nucleotide polymorphisms (SNPs) within the VDR gene: FokI (rs2228570), BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236). The VDR is a nuclear receptor expressed in various immune cells, including monocytes, dendritic cells, and activated T lymphocytes, which mediates the biological effects of vitamin D by regulating the transcription of genes involved in immune regulation and skeletal metabolism. By genotyping these specific variants using real-time polymerase chain reaction (PCR), the investigators sought to determine whether genetic susceptibility to JIA or the physiological response to vitamin D supplementation is modulated by these receptor variations in a Middle Eastern and North African population, where such data have previously been limited.

The study population consisted of 120 JIA patients, aged between 2 and 16 years, with a mean age of 10.75 years, and 100 healthy volunteers matched for age, sex, body mass index, and socioeconomic status. The JIA cohort included a predominance of females, with 80 females and 40 males, and the disease duration ranged from 0.5 to 12 years. Patients were diagnosed according to the Revised Classification Criteria of the International League of Associations for Rheumatology (ILAR). Exclusion criteria were strictly applied to ensure that vitamin D levels were not confounded by other metabolic or systemic conditions; children with known nutritional disorders such as severe malnutrition or rickets, as well as those with renal dysfunction, liver disease, parathyroid diseases, malabsorption syndromes, or other connective tissue diseases, were excluded from the analysis.

Baseline laboratory investigations revealed a significant disparity in vitamin D status between the JIA patients and the healthy controls. Serum 25-hydroxyvitamin D levels were measured using Enzyme Linked Immunosorbent assay (ELISA) before and after a three-month supplementation period. The mean serum 25-hydroxyvitamin D level in JIA patients was 25.60 ± 9.68 ng/mL, significantly lower than the 38.76 ± 7.22 ng/mL observed in controls (p < 0.001). Among the JIA patients, 58.3% had vitamin D deficiency (defined as < 20 ng/mL), 25% had insufficiency (20–30 ng/mL), and only 16.7% had sufficient levels (> 30 ng/mL). In contrast, 22% of the healthy controls had sufficient levels, 72% had insufficiency, and 6% had deficiency. These findings align with broader epidemiological evidence suggesting a high prevalence of vitamin D insufficiency among children with autoimmune and inflammatory conditions.

The study also assessed the correlation between serum vitamin D levels and clinical disease activity in JIA patients. Disease activity was evaluated using the Juvenile Arthritis Disease Activity Score 10 (JADAS 10) and the Childhood Health Assessment Questionnaire (CHAQ). A significant negative correlation was found between serum vitamin D levels and markers of disease activity, including the number of active joints, JADAS 10 scores, and acute phase reactants such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Conversely, serum vitamin D levels showed a significant positive correlation with hemoglobin and serum calcium levels. These associations suggest that lower vitamin D status may be linked to higher inflammatory burden and disease activity in JIA, although the authors emphasize that these are correlational findings and do not establish a causal relationship between vitamin D deficiency and disease progression.

Regarding genetic susceptibility, the distribution of VDR polymorphisms was compared between JIA patients and healthy controls. No significant differences were found for the BsmI, ApaI, or TaqI polymorphisms. However, the FokI polymorphism showed a statistically significant difference in the recessive inheritance model between patients and controls, suggesting a potential association between this specific VDR variant and JIA susceptibility in Egyptian children. Furthermore, a significant difference was observed in the ApaI polymorphism distribution between JIA patients with low vitamin D levels and those with sufficient levels; the Aa genotype of the ApaI polymorphism was significantly more represented in patients with sufficient serum vitamin D levels (70%) compared to those with low levels (44%). No significant differences in VDR polymorphism distribution were found between active and non-active JIA patients.

All participants with vitamin D deficiency or insufficiency, totaling 178 individuals, received oral vitamin D supplementation at a daily dose of 1000 IU for three months. This standardized regimen was selected based on local clinical practice and pediatric recommendations to allow for the evaluation of potential differences in vitamin D response according to VDR genotype. The primary outcome of the supplementation phase was the change in serum 25-hydroxyvitamin D levels from baseline to the end of the three-month period. The study design allowed for the assessment of whether specific VDR genotypes predicted a greater increase in vitamin D levels, thereby identifying potential pharmacogenomic markers for treatment response.

The results of the supplementation phase revealed a significant association between specific VDR genotypes and the magnitude of the vitamin D response. In JIA children, the FF genotype of the FokI polymorphism and the tt genotype of the TaqI polymorphism were associated with a better response to supplementation. Specifically, patients with the FokI FF genotype showed an increase in serum 25-hydroxyvitamin D from 25.3 ng/mL to 50.4 ng/mL, while those with the TaqI tt genotype increased from 30.8 ng/mL to 55.4 ng/mL. In contrast, no significant association was found between the response to supplementation and the ApaI or BsmI polymorphisms. Notably, similar associations between FokI and TaqI genotypes and supplementation response were observed in the healthy control group, suggesting that these genetic variations may influence general vitamin D metabolism and responsiveness rather than being specific to the pathophysiology of JIA.

To identify independent predictors of treatment response, the researchers performed a multiple linear regression analysis, adjusting for potential confounding variables such as age, sex, and JADAS scores. The FokI genotype (β = 0.31, P = 0.003), TaqI genotype (β = 0.24, P = 0.018), and baseline vitamin D level (β = − 0.28, P = 0.010) remained significant independent predictors of the response to vitamin D supplementation in JIA patients. Age, sex, and JADAS scores were not significantly associated with treatment response in the multivariate model. These findings indicate that genetic factors, particularly the FokI and TaqI variants, play a measurable role in determining how effectively children with JIA respond to standard vitamin D supplementation, independent of their baseline disease activity or demographic characteristics.

The study acknowledges several limitations that must be considered when interpreting the results. The observational design and the use of a fixed daily dose of 1000 IU for all participants limit the ability to determine optimal dosing strategies based on genotype. Additionally, the absence of a placebo supplementation group and the lack of treatment adherence assessment make it difficult to definitively attribute the observed changes in vitamin D levels solely to the biological effects of the VDR polymorphisms. The study also did not include subgroup analyses according to JIA subtype, nor did it correct for multiple comparisons, which may affect the statistical robustness of the genetic associations. Furthermore, the laboratory analyses were performed at an external laboratory, and detailed methodological information regarding quality-control measures was limited.

The authors note that the conflicting findings in the existing literature regarding VDR polymorphisms and JIA susceptibility may reflect ethnic and geographic differences in allele frequencies, variation in sample size, and heterogeneity of JIA subtypes. While some studies have reported significant associations between FokI variants and JIA, others have failed to identify such links, and several have found that vitamin D status is independent of VDR genotypes. The current evidence does not support a consistent role for individual VDR polymorphisms as universal genetic markers of JIA susceptibility. However, the finding that FokI and TaqI genotypes predict supplementation response in both JIA patients and healthy controls suggests a broader physiological role for these variants in vitamin D metabolism.

In conclusion, this study highlights the high prevalence of vitamin D deficiency in Egyptian children with JIA and its correlation with disease activity. It provides evidence that VDR FokI and TaqI polymorphisms are associated with the response to vitamin D supplementation, although the similar findings in healthy controls suggest that these associations may reflect general metabolic responsiveness rather than a JIA-specific mechanism. The authors emphasize that while VDR genotyping may have potential utility in predicting treatment response, further larger prospective multicenter studies with standardized supplementation protocols are needed to confirm these findings and establish the clinical value of VDR genotyping in the management of JIA. Until such evidence is available, VDR polymorphisms should not be considered reliable biomarkers for JIA susceptibility or routine treatment response prediction.

Subject of Research: Association between vitamin D receptor gene polymorphisms and vitamin D supplementation in juvenile idiopathic arthritis: an observational case–control study

Article Title: Association between vitamin D receptor gene polymorphisms and vitamin D supplementation in juvenile idiopathic arthritis: an observational case–control study

Article References: El-Banna, H., Hablas, S., Mohamed, A., Ibrahim, M., El-sharkawy, A., El-Bohy, D., & Abd Elmoneam, S. (2026). Association between vitamin D receptor gene polymorphisms and vitamin D supplementation in juvenile idiopathic arthritis: an observational case–control study. Egyptian Rheumatology and Rehabilitation, 53(1), Article 68. https://doi.org/10.1186/s43166-026-00433-w

Image Credits: AI Generated

DOI: 10.1186/s43166-026-00433-w

Keywords: Association, between, vitamin, receptor, gene, polymorphisms, supplementation, juvenile, idiopathic, arthritis, observational, case

News Source: Ophelia Keating. (November 7, 2026). VDR Genotypes Predict Vitamin D Response in Juvenile Arthritis. Scienmag.

Tags: arthritisAssociationbetweencasegeneidiopathicjuvenileobservationalpolymorphismsreceptorsupplementationVitamin
Share12Tweet7Share2ShareShareShare1

Related Posts

Prematurity and Delivery Complications Predict Neonatal Mortality in Rural Northern Uganda

Prematurity and Delivery Complications Predict Neonatal Mortality in Rural Northern Uganda

November 17, 2026
Charting Patient Nonadherence Reduces Clinician Empathy in Randomized Survey Experiment

Charting Patient Nonadherence Reduces Clinician Empathy in Randomized Survey Experiment

November 17, 2026

Inhibiting MCP-1 Reduces BMP-2 and Crystal Adhesion in Injured Kidney Cells

November 17, 2026

Self-reports capture more miscarriages than healthcare records in Finnish study

November 17, 2026

POPULAR NEWS

  • Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

    Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

    29 shares
    Share 12 Tweet 7
  • Review Links Skin Microbiota and T-Cell Crosstalk to Venous Disease Progression

    29 shares
    Share 12 Tweet 7
  • Pre-Curing Rheology Enables Electrospun Silicone Elastomer Coatings for Cochlear Implants

    29 shares
    Share 12 Tweet 7
  • Solvothermal Synthesis Yields Bismuth Selenide Nanoparticles with Distinct Phonon Modes

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Fungus Yields Over Sixty Percent Lipids and Shows Broad Antimicrobial Effects

Combining Auxin and Citric Acid Maximizes Heavy Metal Extraction in Castor Plants

Prematurity and Delivery Complications Predict Neonatal Mortality in Rural Northern Uganda

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.